Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00735332
Recruitment Status : Terminated (License termination.)
First Posted : August 14, 2008
Last Update Posted : August 5, 2010
Information provided by:
Thallion Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2009
  Estimated Study Completion Date : October 2010